Ferns N Petals, India's leading luxury brand, has announced the launch of 'MediJourney'. The world's new health tourism sector.
Research-based motivators to foster imaginative medications can assist the innovative drug area with being worth USD 200 billion by 2030, Biocon Chief Director Kiran Mazumdar-Shaw said. She noted that the pharmaceutical sector has even greater...
Venus Remedies has been awarded a Good Manufacturing Practice (GMP) certificate for its facilities by the Libyan Ministry of Health. Libya's pharmaceutical imports, estimated at $514 million in 2021, increased by 2.81 percent compared to the...
Galytix, a GenAI platform, and Foyer Global Health, an international health insurance company of foreign companies, have announced a collaboration to present HealthX, a digital health platform for insurance companies. The International Private...
Early-stage biotechnology company Virios Therapeutics, Inc. announced plans to use IMC-2 (a combination of valacyclovir and celecoxib) to treat fatigue, orthostatic intolerance and other symptoms of LC (also known as post-acute). Consequences of...
AstraZeneca Pharma India Ltd has announced that it has received approval from the Indian Standard Drugs Control Organization (CDSCO) to import and market Andexanet Alfa. FXa inhibitors are used to prevent and treat thrombotic events such as deep...
The Indian government should allocate more funds for research and development, health funds and drug innovations in the health sector, industry experts expect in the 2024 budget
Wipro GE Healthcare, global healthcare technology specialist, developer and provider of digital solutions, has signed a memorandum of understanding (MOU) with India's premier research institute.
The U.S. health regulator said on Monday companies will be required to add a serious warning on the prescribing information for cancer therapies known as CAR-T, made by Gilead Sciences, Johnson & Johnson, Novartis and others.
Curasight A/S (Curasight), a global leader in radiology, announced that it has achieved the first milestone in the development of Curasight's uTRACE PET imaging technology for the treatment of prostate cancer through an agreement with Curium Inc
, CDSCO.jpg)
.jpg)